When the federal government enhanced patent protection for drugs roughly 2 decades ago,
critics feared the end result would be soaring drug costs and conversion of the Canadian …

In 1987, the government passed legislation to protect brand-name pharmaceutical firms
against competition from generic drug brands in exchange for economic investment in …

RE: Patented Medicine Prices Review Board resignations | CMAJ Skip to main content Main
menu Home Content Current issue Past issues Early releases Collections Sections Blog …

Over the past several years, the federal government has consulted widely in formulating new
rules for the regulation of brand-name drug prices through the Patented Medicine Prices …

The brand-name pharmaceutical industry pledged last week to fight all efforts by generic
drug manufacturers to weaken current patent protections, saying such efforts would rob …

A bitter decade-long dispute over pharmaceutical patent protection in developing countries
has become exceptionally costly. The clash between the pharmaceutical industry and …

The cost of drugsin the United States has emerged as a
focalpointforreducingoverallhealthcarecosts. 1, 2 Canada, like many countries around the …

Round one was an epic political struggle between the international brand-name drug
companies-the research-based side of the industry-and the upstart domestic producers of …

Healthcare cost inflation and the lack of accessibility, particularly for the poor, pose a
significant challenge for United States' officials. Since solving the latter threatens to …

Lengthen effective patent protection in industrial countries and press developing countries to
introduce patent protection. These two tactics have become important parts of the R&D …